fbpx
01 / 05
Stuff of Progress, Pt. 10: Synthetic Pharmaceuticals

Blog Post | Health & Medical Care

Stuff of Progress, Pt. 10: Synthetic Pharmaceuticals

Synthetic Pharmaceuticals

In 1853, a French chemist named Charles Frédéric Gerhardt did something remarkable. He mastered an understanding of salicin, a naturally occurring chemical compound derived from the bark of willow trees – and went on to chemically synthesize salicylic acid, a synthetic form of natural salicin and civilization’s first synthetic pain reliever. In doing so, he helped to kick off the Pharmaceutical Revolution.

Humans had been unknowingly using the salicin found in many plants, but most especially willow bark, to treat pain since at least 1500 BCE, starting in Mesopotamia and Egypt. But knowing that a plant contains a useful treatment and understanding how to artificially synthesize that treatment from scratch are two very different things.

Mastering that technological jump in pharmaceutical chemistry took over three thousand years. Aside from pain relief, salicin had another great advantage. It could reduce inflammation, and break a fever, particularly in children.

Between 1897 and 1899, a German chemist named Felix Hoffmann, refined the process of synthesizing acetylsalicylic acid, a refined and improved form of the synthetic salicylic acid, while undertaking work for the Bayer Pharmaceutical Company based in Germany. The name that Bayer gave to the first mass produced pharmaceutical is as much a household name today as it was at the turn of the century. That name was Aspirin.

By 1950, Aspirin had become the most consumed painkiller globally. Today, we consume more than a hundred billion Aspirin tablets annually. Unlocking the chemistry and technology required to produce acetylsalicylic acid was the key to developing the first in a series of tens of thousands of natural and synthetic pharmaceutical compounds produced between the height of the Industrial Revolution and today.

It is all too easy to forget how greatly modern pharmaceuticals have transformed our collective lives. From insulin to modern contraceptive tablets and from acetaminophen to paracetamol, these compounds run the spectrum from life enriching to literally life-saving.

The U.S. Food and Drug Administration (FDA) alone regulates an estimated 20,000 prescription drugs and chemical compounds used to treat thousands of conditions. The pharmaceutical compounds we have at our disposal have helped to dramatically reduce the burden of disease in both the developed and developing world.

Scientific progress,  stimulated by expanding and largely free globalized trade network, helped to advance both the development and utilization of key pharmaceutical breakthroughs. It is no exaggeration to say that some of the more prominent pharmaceutical drugs significantly impacted life expectancy averages, as well as our general wellbeing.

Starting at the dawn of the Industrial Revolution, civilization began to turn out a series of groundbreaking pharmaceutical drugs, antibiotics, vaccines and much more. Some of those key drugs included Ether and Morphine, powerful pain blockers, invented in 1842 and 1827 respectively. Insulin, an effective diabetes treatment, was developed in 1922; penicillin, a powerful antibiotic, in 1942; drug treatments for tuberculosis in 1951; oral contraceptives in the 1960s; salbutamol to treat asthma in 1966; and a series of effective chemotherapy drugs and HIV inhibitors in the 1990s.

Humanity has accomplished all that and more. Powerful modern anesthetics, antibiotics, antimalarials or vaccines which have also saved hundreds of millions of lives – especially those of children.

Today the global pharmaceutical market is worth more than 1.1 trillion U.S. dollars, having grown by more than 5 percent over the previous year alone.The same market forces, which have helped to provide inexpensive and abundant energy, and fast and reliable communications and travel, have also helped to drive forward an industry that has improved the health and wellbeing of billions.

Today, most people living in developed countries have relatively inexpensive access to a vast spectrum of affordable over the counter and prescription medications, the likes of which couldn’t have been dreamed of by even the most optimistic medical chemists of the late 1800s.

For less than the price of a coffee, you can rid yourself of a headache, take a dose of antibiotic to treat an infection, break a child’s fever, provide a dose of oral rehydration therapy or allergy antihistamine. The good news is that innovation and progress within the pharmaceutical industry continues to drive human progress.

That is all the more important as the world’s scientists race to develop inexpensive, effective and swiftly deployable treatments and vaccines to combat the SARS-COV-2 coronavirus pandemic.

Red Deer Advocate | Drug Use

Canada Sees 23 Percent Opioid Death Reduction in 2025

“Opioid-related drug deaths in Canada declined by 23 per cent from 2024 to 2025, but remain elevated above pre-pandemic levels, according to data released by the federal government on Monday, June 15.

Across Canada, an average of 15 people per day died as a result of using opioids illegally in 2025, for a yearly total of 5,608. Deaths had spiked from 3,598 in 2019 to a pandemic-era high of 8,040 in 2023, but have been declining steadily since…

The government reports that stimulant-related deaths have also decreased year-over-year by 31 per cent. This progress is very uneven across Canada, with many regions seeing those deaths now outpacing opioid-related fatalities. This is the case in Saskatchewan, Manitoba, Ontario, New Brunswick, Newfoundland and Labrador, and the Northwest Territories.”

From Red Deer Advocate.

Trust for America's Health | Drug Use

US Deaths from Drugs, Alcohol, and Suicide Continue Decline

“After two decades of rising deaths from alcohol, drugs, and suicide, the United States is at a turning point. Recent declines in mortality suggest meaningful progress, but that progress is fragile. Over the past year, the federal behavioral health and injury prevention systems that support prevention, surveillance, and crisis response have experienced leadership upheaval, funding disruptions, and workforce reductions.  Whether recent gains continue will depend on sustained investment in the public health infrastructure that makes prevention possible.

After peaking in 2021, this year’s report finds that the combined age-adjusted rate of deaths from alcohol, drugs, and suicide declined by 16 percent in 2024, building on a decrease of 4 percent in 2023.  Specifically, alcohol-induced mortality declined by 4 percent, drug overdose mortality by 26 percent, and suicide mortality by 3 percent.”

From Trust for America’s Health.

Journal Of Global Health | Drug Use

Global Substance Use Disorder Rates Declined Since 1990

“In 2021, 162.86 million people had substance use disorders (95% UI = 145.95, 180.85).

The global age-standardised prevalence rate was 1982.13 per 100 000 (95% UI = 1773.57, 2206.29), declining by 16.9% (95% UI = −18.7, −14.9) since 1990; age-standardised incidence rate was 843.37 (95% UI = 736.21, 956.19), declining by 17.3% (95% UI = −19.7, −15.2).”

From Journal Of Global Health.